Your browser doesn't support javascript.
loading
Long-term follow-up of rituximab in treatment of chronic graft-versus-host disease-single center experience.
Klobuch, Sebastian; Weber, Daniela; Holler, Barbara; Edinger, Matthias; Herr, Wolfgang; Holler, Ernst; Wolff, Daniel.
Afiliação
  • Klobuch S; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany. sebastian.klobuch@ukr.de.
  • Weber D; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Holler B; Regensburg Center for Interventional Immunology, University Hospital Regensburg, Regensburg, Germany.
  • Edinger M; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Herr W; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Holler E; Regensburg Center for Interventional Immunology, University Hospital Regensburg, Regensburg, Germany.
  • Wolff D; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Ann Hematol ; 98(10): 2399-2405, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31375860

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rituximab / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rituximab / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article